ViewRay Akcija

ViewRay EPS

ViewRay (VRAYQ) Pelnas vienai akcijai (EPS) 2026-08-13 dieną yra −0,59 USD. Praėjusiais metais Pelnas vienai akcijai (EPS) buvo −0,64 USD — pokytis −7,92% (didesnis).

EPS

−0,59USD

YoY

−7,92%

Paskutinį kartą atnaujinta:

ViewRay Pelnas vienai akcijai (EPS) yra 2026 −0,59 USD. ViewRay Pelnas vienai akcijai (EPS) buvo 2025 −0,64 USD. Tai sumažėjo −7,92% didesnis lyginant su praėjusiais metais.
Access this data via the Eulerpool API

ViewRay Akcijų analizė

Ką veikia ViewRay? ViewRay Inc. is an American medical technology company based in Cleveland, Ohio. It was founded in 2004 by Ivor Jankovic and specializes in the manufacturing of radiation therapy devices. The history of ViewRay begins with the idea of developing innovative technology to treat cancer patients more effectively and gently. In 2005, the company entered into an agreement with the Cleveland Clinic Lerner Research Institute to conduct research on a novel magnetic resonance-guided radiation therapy machine. The research project was led by James F. Dempsey, Chair of the Department of Radiation Oncology at the Cleveland Clinic. In 2009, the first magnetic resonance-guided radiation therapy system was delivered and implemented at the Cleveland Clinic. ViewRay's business model is based on the development and manufacturing of innovative medical devices aimed at making the treatment of cancer patients more effective and gentle. The company focuses on combining magnetic resonance imaging (MRI) and radiation therapy to ensure more precise and safer treatment. ViewRay offers various products, including the MRIdian-Linac system, an advanced radiation therapy device that utilizes MRI technology to provide real-time images of the tumor during radiation. This allows for precise targeting of the tumor while sparing the surrounding tissue. The system also offers the ability to sync radiation therapy with the patient's breathing cycle, further improving the accuracy and effectiveness of the treatment. In addition to the MRIdian-Linac system, ViewRay also offers the MRIdian-MRI system, which is solely dedicated to imaging. The MRIdian-MRI is a diagnostic instrument that allows for better visualization of tissue and tumor studies. The system uses the same MRI technology as the MRIdian-Linac to generate radiation-free images. ViewRay has also specialized in the development of software tools that assist doctors in better planning and monitoring radiation therapy. This includes the RayCare Oncology Information System, which provides a comprehensive workflow and management platform, as well as the RayStation Treatment Planning Software, which enables more precise radiation therapy planning. In terms of market reach, ViewRay has a global presence. The company has a strong presence in North America, Europe, and Asia, and works closely with leading research institutes and hospitals to evaluate and improve the effectiveness and efficiency of its technologies. Overall, ViewRay has developed an innovative and unique portfolio of products and solutions that improve radiation therapy and increase accuracy and safety for patients and doctors. The company is a leader in the development of MRI-guided radiation therapy systems and is expected to continue playing a significant role in the medical technology industry in the future. ViewRay yra viena populiariausių kompanijų Eulerpool.com.

Dažniausiai užduodami klausimai apie ViewRay akciją

ViewRay Pelnas vienai akcijai (EPS) 2026 m. yra −0,59 USD.

ViewRay Pelnas vienai akcijai (EPS) pasikeitė nuo −0,64 USD iki −0,59 USD, tai atitinka −7,92% pokytį. Reikšmė yra didesnis nei praėjusiais metais.

Eulerpool rasite visą Pelnas vienai akcijai (EPS) ViewRay istorinę raidą nuo 2006 m. – su metinėmis reikšmėmis, grafikais ir išsamiomis analizėmis.

Pelnas vienai akcijai matuoja to įmonės pelno dalį, kuri tenka kiekvienai išleistai akcijai. Tai pagrindinė metrika, skirta vertinti įmonės pelningumą.

EPS = Grynasis pelnas / Išleistos akcijos

Access this data via the Eulerpool API

Pelno ir nuostolių ataskaita — ViewRay

Visi pagrindiniai rodikliai — ViewRay